LMAT
LEMAITRE VASCULAR INCPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 25 ▲ LeMaitre Vascular (LMAT) reported strong Q4 2025 results with revenu…
- Feb 26 ▼ Lemaitre Vascular CEO George LeMaitre sold 150,000 shares for $16.0M…
- May 5 Dividend: LeMaitre Q1 2026 Financial Results
- May 5 ▲ LeMaitre Vascular reported Q1 2026 EPS of $0.68 (+42% YoY), a 3% bea…
- Nov 4 ▼ LeMaitre Vascular reported Q3 2026 sales of $68.0M (+11% YoY) and GA…
- Nov 4 ▼ Earnings: LMAT Q3 2026 Earnings: EPS $0.65 (-7.1% vs est)
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells since Jun 4. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q3 2026: 26 added (1 new), 22 trimmed or exited. Largest new: Boston Trust Walden $28.5M.
- AnalystsBULLISH
9 of 14 rate it Buy or better. Every target is above the price.
- Short sellersSTEADY
Short interest −6.7% to 1.66M shares. 6.2 days to cover, ≈7.2% of shares.
- TrendDOWNTREND
5% below its 50-day average. New closing low $77.01 on Nov 16.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| JPMORGAN CHASE & CO | DOUBLED | $34.0M |
| UBS Group AG | ADD | $29.1M |
| Boston Trust Walden Corp | NEW | $28.5M |
| VOYA INVESTMENT MANAGEMENT LLC | DOUBLED | $19.7M |
| PRINCIPAL FINANCIAL GROUP INC | ADD | $12.5M |
| Rockefeller Capital Management L.P. | ADD | $11.9M |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | ADD | $9.2M |
| ProShare Advisors LLC | ADD | $8.5M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
14 analystsPrice is below the lowest target. Median implies +18%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 5, 2026 | Wells Fargo MAINTAIN | Equal-Weight |
| Nov 5, 2026 | Citizens MAINTAIN | Market Outperform |
| Aug 5, 2026 | Wells Fargo MAINTAIN | Equal-Weight |
| Jun 3, 2026 | Barrington Research MAINTAIN | Outperform |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Roberts David B President and Director Sep 3, 2026 | AWARD | 5.287 sh |
Roberts David B President and Director Sep 3, 2026 | AWARD | 0.345 sh |
Roberts David B President and Director Sep 3, 2026 | AWARD | 0.306 sh |
Roberts David B President and Director Sep 3, 2026 | AWARD | 3.576 sh |
Roberts David B President and Director Sep 3, 2026 | AWARD | 3.157 sh |
Roberts David B President and Director Sep 3, 2026 | AWARD | 4.352 sh |
Roberts David B President and Director Sep 3, 2026 | AWARD | 3.632 sh |
Roberts David B President and Director Sep 3, 2026 | AWARD | 2.126 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | $3.15 | $2.97–$3.30 | -0.9% | $303.4M |
Short side
FINRA· Oct 30, 2026SecBot reports
13 filings · 1 press release · 2 bullish · 3 bearish · 8 neutral- BEARISH 8-KNov 4, 2026
LeMaitre Vascular reported Q3 2026 sales of $68.0M (+11% YoY) and GAAP diluted EPS of $0.65…
The EPS miss and lowered full-year guidance are the primary negatives, driven by operating expense growth outpacing sales. Monitor the Q4 call for commentary on expense trajectory, B. Braun product…
- NEUTRAL INST-CLUSTERNov 2, 2026
Three asset managers added or initiated LMAT positions in Q3 2026, with Boston Trust Walden…
The cluster is dominated by active asset managers, but the 45-day reporting lag means positions may have changed since quarter-end. Monitor upcoming 10-Q for fundamental drivers and any insider…
- NEUTRAL 8-KOct 15, 2026
President David B. Roberts notified LeMaitre Vascular of his retirement as an employee and…
Monitor future filings for appointment of a new President or any organizational changes. The retention of Roberts on the board suggests a managed succession, reducing near-term disruption risk.
- NEUTRAL PRESS RELEASEAug 27, 2026
LeMaitre Vascular announced management participation in three upcoming investor conferences. This…
This is a routine conference participation announcement with no trading implications. Monitor for any material updates or presentations at these conferences that could provide new business insights.
All LMAT filing & press-release reports (14)
- 8-K reportNov 4, 2026
- INST-CLUSTER reportNov 2, 2026
- 8-K reportOct 15, 2026
- PRESS-RELEASE reportAug 27, 2026
- PRESS-RELEASE reportJul 14, 2026
- CLUSTER reportMay 7, 2026
- CLUSTER reportMay 7, 2026
- CLUSTER reportMay 7, 2026
- 8-K reportMay 5, 2026
- DEFA14A reportApr 14, 2026
- 8-K reportApr 14, 2026
- CLUSTER reportMar 11, 2026
- CLUSTER reportFeb 26, 2026
- 8-K reportFeb 25, 2026